Kenvue Reports Full Year and Fourth Quarter 2023 Results

FY’23: Net Sales Increased 3.3% to $15.4 billion with Organic Growth1 of 5.0%


FY’23: Diluted Earnings per Share of $0.90; Adjusted Diluted Earnings per Share1 of $1.29


Q4’23: Net Sales...

Related Keywords

China ,United States ,Russia ,America ,Johnson ,Asia Pacific ,Paul Ruh ,Thibaut Mongon ,New York Stock Exchange ,Company Net ,Women Health ,Kenvue Inc ,Company Cash ,Us Skin Health ,Skin Health ,Exchange Commission ,York Stock Exchange ,Chief Executive ,Fourth Quarter ,Chief Financial ,Brand Adhesive Bandages ,Deferred Markets ,Private Securities Litigation Reform Act ,Quarterly Reports ,Consolidated Statement ,Millions Except Per Share Data ,Three Months Ended December ,Net Sales ,Three Months Ended January ,Twelve Months Ended December ,Twelve Months Ended January ,Year Organic Growth ,Oral Care ,Gum Therapy ,Segment Net Sales ,Adjusted Operating ,Care Adjusted ,Beauty Adjusted ,Health Adjusted ,Geographic Region ,Middle East ,Markets ,